Minimal residual disease with TEL-AML1 fusion transcript in childhood acute lymphoblastic leukaemia with t(12;21)

British Journal of Haematology

Volumn 97, Issue 3, 1997, Pages 607-611

  Satake, Noriko ^a   Kobayashi, Hirofumi ^a   Tsunematsu, Yukiko ^b   Kawasaki, Hajime ^c   Horikoshi, Yasuo ^d   Koizumi, Shoichi ^e   Kaneko, Yasuhiko ^a  

^a Saitama Cancer Centre Hospital   (Japan)

^b NATIONAL CHILDREN S HOSPITAL   (Japan)

^c MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d SHIZUOKA CHILDREN'S HOSPITAL   (Japan)

^e KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

12; 21 translocation; childhood acute lymphoblastic leukaemia; minimal residual disease; RT PCR; TEL AML1 fusion transcript

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ALTERNATIVE RNA SPLICING; ANALYTIC METHOD; ARTICLE; B LYMPHOCYTE ACTIVATION; CYTOGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MINIMAL RESIDUAL DISEASE; PRIORITY JOURNAL; RELAPSE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0030984969     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.762712.x     Document Type: Article

References (16)

1. Campana, D. & Pui, C-H. (1995) Detection of minimal residual disease in acute leukemia: methodologic advances and clinical significance. Blood, 85, 1416-1434.
2. Cayuela, J.-M., Baruchel, A., Orange, C., Madani, A., Auclerc, M.F., Daniel, M.-T., Schaison, G. & Sigaux, F. (1996) TEL-AML1 fusion RNA as a new target to detect minimal residual disease in pediatric B-cell precursor acute lymphoblastic leukemia. Blood, 88, 302-308.
3. Golub, T.R., Barker, G.F., Bohlander, S.K., Hiebert, S.W., Ward, D.C., Bray-Ward, P., Morgan, E., Raimondi, S.C., Rowley, J.D. & Gilliland, D.G. (1995) Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. Proceedings of the National Academy of Sciences of the United States of America, 92, 4917-4921.
4. Hanada, M. & Sakurai, M. (1989) Acute leukemia. Shouni Naika, 21, 739-753.
5. Kim, D.-H., Moldwin, R.L., Vignon, C., Bohlander, S.K., Suto, Y., Giordano, L., Gupta, R., Nucifora, G., Rowley, J.D. & Smith, S.D. (1996) TEL-AML1 translocations with TEL and CDKN2 inactivation in acute lymphoblastic leukemia cell lines. Blood, 88, 785-794.
6. Kobayashi, H., Satake, N. & Kaneko, Y. (1997) Detection of the der(21)t(12:21) chromosome forming the TEL-AML1 fusion gene in childhood acute lymphoblastic leukemia. Leukemia and Lymphoma, in press.
7. Kobayashi, H., Satake, N., Maseki, N., Sakashita, A. & Kaneko, Y. (1996) The der(21)t(12:21) chromosome is always formed in a 12;21 translocation associated with childhood acute lymphoblastic leukaemia. British Journal of Haematology, 94, 105-111.
8. Koizumi, S., Fujimoto, T., Takeda, T., Yatabe, M., Utsumi, J., Mimaya, J., Ninomiya, T. & Yanai, M. (1988) The Japanese Children's Cancer and Leukemia Study Group. Comparison of intermittent or continuous methotrexate plus 6-mercaptopurine in regimens for standard-risk acute lymphoblastic leukemia in childhood (JCCLSG-S811). Cancer, 61, 1292-1300.
9. Nakao, M., Yokota, S., Taniwaki, M., Kashima, K., Sonoda, Y., Koizumi, S., Takaue, Y., Matsushita, T., Fujimoto, T. & Misawa, S. (1996) Detection and quantification of TEL/AML1 fusion transcripts by polymerase chain reaction in childhood acute lymphoblastic leukemia. Leukemia, 10, 1463-1470.
10. Nakazawa, S., Kinoshita, A., Tsuchida, M., Hosoya, R., Nishimura, K., Yamamoto, M., Ueda, Y., Hoshi, N., Akatsuka, J., Bessbo, F., Tsunematsu, Y., Koide, R., Taguchi, N., Yamamoto, K., Nishihira. K., Nagao, T,. Ikuta, K., Matsuyama, S., Okimoto, Y., Sato, T., Yamada, K., Ishikawa, K., Tukada, M., Akabane, T., Ohira, M., Chihara, H., Yamada, K., Sugita, K., Furukawa, T., Okawa, Y., Yata, J., Shibuya, A., Kaneko, T., Otsuki, H., Inana, I., Wada, M., Ishimoto, K., Kaneko, M., Ito, K., Gunji, Y., Kato, S. & Saito, T. (1991) Treatment of childhood acute lymphoblastic leukemia: the results of the Tokyo Children's Cancer Study Group L84-11 treatment protocol study. Developments in Oncology, 267-177.
11. Ogawa, E., Maruyama, M., Kagoshima, H., Inuzuka, M., Lu, J., Satake, M., Shigesada, K. & Ito, Y. (1993) PEBP2/PEA2 represents a family of transcription factors homologous to the products of the Drosophila runt gene and the human AML1 gene. Proceedings of the National Academy of Sciences of the United States of America, 90, 6859-6863.
12. Raynaud, S., Cavé, H., Baens, M., Bastard, C., Cacheux, V., Grosgeorge, J. Guidal-Giroux, C., Guo, C., Vilmer, E., Marynen, P. & Grandchamp, B. (1996) The 12;21 translocation involving TEL and deletion of the other TEL allele: two frequently associated alterations found in childhood acute lymphoblastic leukemia. Blood, 87, 2891-2899.
13. Romana, S.P., Mauchauffé, M., Le Coniat, M., Chumakov, I., Le Paslier, D., Berger, R. & Bernard, O.A. (1995a) The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion. Blood, 85, 3662-3670.
14. Romana, S.P., Poirel, H., Leconiat, M., Flexor, M.-A., Mauchauffé, M., Jonveaux, P., Macintyre, E.A., Berger, R. & Bernard, O.A. (1995b) High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia. Blood, 86, 4263-4269.
15. Satake, N., Maseki, N., Kozu, T., Sakashita, A., Kobayashi, H., Sakurai, M., Ohki, M. & Kaneko, Y. (1995) Disappearance of AML1-MTG8(ETO) fusion transcript in acute myeloid leukaemia patients with t(8;21) in long-term remission. British Journal of Haematology, 91, 892-898.
16. Shurtleff, S.A., Buijs, A., Behm, F.G., Rubnitz, J.E., Raimondi, S.C., Hancock, M.L., Chan, G.C.-F., Pui, C.-H., Grosveld, G. & Downing, J.R. (1995) TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. Leukemia, 9, 1985-1989.